News blog


  • BY: Andrew Hore |
  • POSTED: 04/05/2011 |

Advanced cleantech and biomedical materials developer Ilika says joint development and contract research revenues grew substantially in the year to April 2011.

Revenues grew 48% to £1.9m in 2010-11 and committed revenues for the six months to October 2011 already exceed £700,000.
Ilika will report a loss slightly lower than the £3.26m made in 2009-10. There is still £3.26m in the bank.

Ilika expects to commercialise its material used to increase hydrogen storage capacity at some point during 2012.

Performance testing for Ilika’s low cost fuel cell will take place in the current financial year.
At 49.5p a share, Ilika is valued at £18.1m.

Full year figures should be published in the middle of July.

See more quoted cleantech company news on

© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds